Drugs

Pro wrestling icon Ric Flair and co-founder of ‘Drip Cannabis’ Chad Bronstein share why they launched a cannabis company on 'Kennedy.'

The U.S. Food and Drug Administration approved Cidara Therapeutics and Melinta Therapeutics' antifungal drug for patients with little to no other options.

The Justice Department filed a lawsuit against Rite Aid for allegedly filling out "hundreds of thousands" of unlawful prescriptions, contributing to the opioid crisis.

USDA took no action against drug maker Envigo who had to forfeit 4,000 beagles after mistreating them. Envigo settled civil charges but Grand Jury explores legal options.

To avoid government penalties for raising drug prices, pharmaceutical companies are releasing drugs at higher prices with hefty rebates to maintain profitability.

Doctors tell FOX Business that there are a handful of barriers keeping people from being able to take Wegovy and Ozempic including insurance coverage, high cost and availability issues.

The FDA will decide on July 6 whether to grant full approval to the new Alzheimer's treatment Leqembi, Japanese drugmaker Eisai and its U.S. partner Biogen said.

The Lavenir family filed a wrongful death lawsuit against Airbnb, a rental owner, and the prior renter after their 19-month-old daughter died due to fentanyl exposure.

The Washington State Liquor and Cannabis Board is offering available retail licenses to sell marijuana, prioritizing former offenders in the name of "social equity."

House Republicans are investigating pharmacy-benefit managers, middlemen in drug price negotiations, over whether they create unnecessary costs for prescription drugs.

Two UPS employees are part of a group of five accused of trafficking cocaine in southern Texas. Law enforcement seized approximately 60 kilograms of cocaine.

A panel urged the FDA to give final approval to a plan that would make Narcan, the nasal version of the overdose-reversal drug naloxone, available over the counter.

Twitter has updated its policies to allow cannabis companies to advertise on the platform, becoming the first major social media company to roll out the option.

Drugmakers win battle in Third Circuit Court of Appeals over Health Resources and Services Administration, as courts decided HRSA went beyond the law with regulatory overreach.

The FDA said Thursday that there are still too many unknowns about the burgeoning market for CBD products to regulate them as either food or supplements.

Juul is looking for a new backer as FDA order banning its vaporette remains in limbo pending trial. Talks have included Philip Morris, Japan Tobacco Group, and Altria.

The company continues to see pressure on sales from staffing shortages at hospitals, which have limited growth in procedures using J&J products, while inflation has boosted expenses.

Lilly said it would work with the FDA to evaluate the fastest pathway to get its Alzheimer’s drug to market after what it believes was a successful trial.

Oklahoma announced new settlements totaling $226.1 million with three pharmacy chains and a drug manufacturer over the opioid epidemic on Wednesday.

New York's first legal recreational marijuana dispensary, Housing Works Cannabis Co, opened in Lower Manhattan on Thursday, with dozens of others on the way.